Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP)
34.54
-3.17 (-8.41%)
NASDAQ · Last Trade: Jun 12th, 5:25 PM EDT
Tonix Pharmaceuticals has filed a registration statement to sell up to $500 million in securities. The company's lead drug candidate is for the management of fibromyalgia pain.
Via Benzinga · June 12, 2025
Via Benzinga · June 12, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via Chartmill · June 12, 2025
Via Benzinga · June 12, 2025
The proceeds from the purchase agreement are expected to be used for working capital and general corporate purposes.
Via Stocktwits · June 12, 2025
Via Benzinga · June 12, 2025

Tonix Pharmaceuticals Corp. (NASDAQ:TNXP) shares have nearly doubled over the past month. Here's what you need to know.
Via Benzinga · May 28, 2025
Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · May 16, 2025
Tonix stock surged over 33% this week fueled by insider buying and strong Q1 results. The company's Q1 loss beat estimates.
Via Benzinga · May 16, 2025
In his role at Celgene Corp, Hand played a strategic role in transactions including the $74 billion acquisition of Celgene by Bristol Myers Squibb and its subsequent integration.
Via Stocktwits · May 14, 2025
Shares of Tonix Pharmaceuticals are pulling back 12.7% during Thursday's session. The stock is pulling back following a regulatory update on its experimental fibromyalgia treatment, TNX-102 SL.
Via Benzinga · March 27, 2025
Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.
Via MarketBeat · March 25, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · March 24, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · March 24, 2025
Tonix Pharmaceuticals shares are trading higher by 22.5% during Monday's session. The company announced that the FDA will not require an Advisory Committee meeting for its New Drug Application for TNX-102 SL.
Via Benzinga · March 24, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · March 21, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · March 19, 2025
Via Benzinga · March 19, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · March 19, 2025